Accuray Incorporated
General ticker "ARAY" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $121.9M (TTM average)
Accuray Incorporated does not follow the US Stock Market performance with the rate: -18.4%.
Estimated limits based on current volatility of 2.7%: low 0.25$, high 0.26$
Factors to consider:
- Total employees count: 990 (+0.3%) as of 2025
- China accounted for 23.2% of revenue in the fiscal year ended 2024-06-30
- North and South America accounted for 20.2% of revenue in the fiscal year ended 2024-06-30
- Top business risk factors: Geopolitical risks, Market acceptance, Gross margin maintenance, Liquidity and credit risks, Quarterly sales volatility
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-06-30 to 2028-06-29
- 2026-06-30 to 2027-06-30 estimated range: [0.28$, 0.96$]
- 2027-06-30 to 2028-06-29 estimated range: [0.46$, 1.31$]
Financial Metrics affecting the ARAY estimates:
- Positive: with PPE of -0.7 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -19.24 <= 0.28
- Positive: Shareholder equity ratio, % of 9.40 <= 18.97
Short-term ARAY quotes
Long-term ARAY plot with estimates
Financial data
| YTD | 2024-06-30 | 2025-06-30 | 2026-06-30 |
|---|---|---|---|
| Operating Revenue | $446.55MM | $458.50MM | $401.95MM |
| Operating Expenses | $446.05MM | $450.67MM | $428.39MM |
| Operating Income | $0.50MM | $7.84MM | $-26.44MM |
| Non-Operating Income | $-12.32MM | $-6.71MM | $-20.81MM |
| Interest Expense | $11.62MM | $12.95MM | $35.31MM |
| R&D Expense | $49.73MM | $47.94MM | $37.75MM |
| Income(Loss) | $-11.82MM | $1.13MM | $-47.25MM |
| Taxes | $3.73MM | $2.73MM | $1.95MM |
| Net Income(Loss)* | $-15.54MM | $-1.59MM | $-49.19MM |
| Stockholders Equity | $45.08MM | $81.17MM | $41.70MM |
| Inventory | $138.32MM | $141.02MM | $147.07MM |
| Assets | $468.63MM | $470.24MM | $443.68MM |
| Operating Cash Flow | $-11.90MM | $2.86MM | $-6.98MM |
| Capital expenditure | $3.60MM | $8.52MM | $5.86MM |
| Investing Cash Flow | $-3.60MM | $-8.52MM | $-12.28MM |
| Financing Cash Flow | $-3.95MM | $-4.25MM | $6.98MM |
| Earnings Per Share** | $-0.16 | $-0.02 | $-0.40 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.